News / Events

Dr. Annemieke Van Dongen-Leunis from the Erasmus School of Health Policy and Management, explains the main results of two posters presented during the 24th European Hematology Association congress

In two video interviews - recorded by the Myeloma Patients Europe - Dr. Annemieke Van Dongen-Leunis from the Erasmus School of Health Policy and Management, Erasmus University Rotterdam, explains the results of the research conducted within the MMpredict consortium....

Fourth project team meeting in Stockholm

During the 23th EHA congress in Stockholm, Sweden, we have had the opportunity to host our fourth HORIZON 2020 project team meeting. We had an interactive session in which we discussed the project progress and short term future goals. The meeting was finalized by...

Two-year anniversary!

This month we celebrate the two-year anniversary of our Multiple Myeloma Horizon 2020 research project. Within this period we have made considerable progress towards our central goal of developing a personalized medicine tool that is capable of predicting the most...

HORIZON 2020 – Patient Questionnaire

Myeloma Patients Europe (MPE) is running a survey for European myeloma patients to understand their quality of life and how this is impacted by treatment side-effects.   To gain knowledge about the current Multiple Myeloma (MM) disease situation in Europe, we ask MM...

© MMH2020